Regulation of tonic GABA inhibitory function, presympathetic neuronal activity and sympathetic outflow from the paraventricular nucleus by astroglial GABA transporters.
Neuronal activity in the hypothalamic paraventricular nucleus (PVN), as well as sympathetic outflow from the PVN, is basally restrained by a GABAergic inhibitory tone. We recently showed that two complementary GABA(A) receptor-mediated modalities underlie inhibition of PVN neuronal activity: a synaptic, quantal inhibitory modality (IPSCs, I(phasic)) and a sustained, non-inactivating modality (I(tonic)). Here, we investigated the role of neuronal and/or glial GABA transporters (GATs) in modulating these inhibitory modalities, and assessed their impact on the activity of RVLM-projecting PVN neurons (PVN-RVLM neurons), and on PVN influence of renal sympathetic nerve activity (RSNA). Patch-clamp recordings were obtained from retrogradely labelled PVN-RVLM neurons in a slice preparation. The non-selective GAT blocker nipecotic acid (100-300 microM) caused a large increase in GABA(A)I(tonic), and reduced IPSC frequency. These effects were replicated by beta-alanine (100 microM), but not by SKF 89976A (30 microM), relatively selective blockers of GAT3 and GAT1 isoforms, respectively. Similar effects were evoked by the gliotoxin L-alpha-aminodipic acid (2 mM). GAT blockade attenuated the firing activity of PVN-RVLM neurons. Moreover, PVN microinjections of nipecotic acid in the whole animal diminished ongoing RSNA. A robust GAT3 immunoreactivity was observed in the PVN, which partially colocalized with the glial marker GFAP. Altogether, our results indicate that by modulating ambient GABA levels and the efficacy of GABA(A)I(tonic), PVN GATs, of a likely glial location, contribute to setting a basal tone of PVN-RVLM firing activity, and PVN-driven RSNA.
Park
Jin Bong
JB
Department of Physiology, Medical College of Georgia, 1120 15th St, Augusta, GA 30912, USA.
Jo
Ji Yoon
JY
Zheng
Hong
H
Patel
Kaushik P
KP
Stern
Javier E
JE
D015074:2-Aminoadipic Acid / Q000494:pharmacology; D000818:Animals; D001253:Astrocytes / Q000502:physiology*; D055724:Electrophysiological Phenomena; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology; D018756:GABA Antagonists / Q000494:pharmacology*; D050485:GABA Plasma Membrane Transport Proteins / Q000502:physiology*; D058787:GABA-A Receptor Antagonists; D066298:In Vitro Techniques; D053444:Inhibitory Postsynaptic Potentials; D008297:Male; D009434:Neural Pathways / Q000187:drug effects / Q000502:physiology; D010286:Paraventricular Hypothalamic Nucleus / Q000187:drug effects* / Q000502:physiology*; D018408:Patch-Clamp Techniques; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects / Q000502:physiology
D018691:Excitatory Amino Acid Antagonists; D018756:GABA Antagonists; D050485:GABA Plasma Membrane Transport Proteins; D058787:GABA-A Receptor Antagonists; D011963:Receptors, GABA-A; D015074:2-Aminoadipic Acid
Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1110-9
16243912
Hypertension. 2002 Feb;39(2):275-80
11847197
J Neurophysiol. 2006 May;95(5):2796-807
16452257
Endocrinology. 2006 Aug;147(8):3746-60
16675519
J Neurochem. 1979 Jul;33(1):181-9
458448
J Physiol. 2007 Jul 15;582(Pt 2):539-51
17495040
Prog Biophys Mol Biol. 2004 Feb-Apr;84(2-3):197-215
14769436
Nat Neurosci. 2003 May;6(5):484-90
12679782
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12145-9
1465453
Neuron. 1993 Feb;10(2):165-75
7679913
J Pharmacol Exp Ther. 2005 Jun;313(3):1035-45
15681656
J Neurophysiol. 2004 Jan;91(1):267-73
14715720
Am J Physiol. 1998 Nov;275(5):R1523-9
9791069
Trends Neurosci. 2004 May;27(5):262-9
15111008
Pharmacol Ther. 1997;73(2):121-46
9131721
J Neurosci. 2006 Apr 19;26(16):4216-27
16624942
Neurochem Res. 2000 Oct;25(9-10):1241-4
11059798
Am J Physiol Regul Integr Comp Physiol. 2002 Apr;282(4):R1006-15
11893604
Pflugers Arch. 1994 Nov;429(1):140-2
7708474
J Neurophysiol. 2002 Mar;87(3):1348-62
11877509
J Neurochem. 1988 Mar;50(3):818-23
3339356
Science. 1990 Sep 14;249(4974):1303-6
1975955
J Pharmacol Exp Ther. 2007 Feb;320(2):615-26
17071818
J Neurophysiol. 1996 Apr;75(4):1573-88
8727397
Neuropharmacology. 2007 Jun;52(7):1439-53
17433821
Am J Physiol Heart Circ Physiol. 2008 Aug;295(2):H807-15
18567709
Neurochem Int. 1996 Oct;29(4):335-56
8939442
J Neurosci. 2005 Dec 14;25(50):11553-63
16354913
J Neurosci. 2003 Apr 1;23(7):2618-26
12684447
J Physiol. 1998 Dec 1;513 ( Pt 2):521-30
9807000
J Neurophysiol. 2002 May;87(5):2624-8
11976398
J Neurosci. 2004 Sep 22;24(38):8379-82
15385620
J Biol Chem. 1992 Sep 5;267(25):17491-3
1517200
Hypertension. 2003 Dec;42(6):1124-9
14597646
Hypertension. 2003 Oct;42(4):725-31
12900439
Neuroscience. 2008 Jun 2;153(4):1332-43
18440149
J Neuroendocrinol. 2005 Jul;17(7):413-23
15946159
Pharmacol Biochem Behav. 2002 Mar;71(3):457-68
11830180
J Physiol. 1996 Dec 15;497 ( Pt 3):753-9
9003560
Nebr Med J. 1996 Dec;81(12):419-23
9046793
Neuroscience. 2003;118(3):585-601
12710969
J Biol Chem. 1993 Jan 25;268(3):2106-12
8420981
Hypertension. 2001 Feb;37(2 Pt 2):614-8
11230344
Neuroscience. 1999;89(4):1319-29
10362317
Exp Physiol. 2003 May;88(3):335-42
12719758
J Physiol. 2007 Aug 1;582(Pt 3):1219-38
17525115
J Neurosci Res. 2001 May 1;64(3):218-22
11319765
Physiol Rev. 2006 Jul;86(3):1009-31
16816144
J Neurosci. 2003 Mar 15;23(6):2032-9
12657661
J Neurophysiol. 2001 Dec;86(6):2823-33
11731539
Hypertension. 1999 Dec;34(6):1301-7
10601134
Clin Exp Pharmacol Physiol. 1998 Jun;25(6):461-3
9673825
Brain Res. 1998 Aug 10;801(1-2):239-43
9729407
Neuroscience. 2003;117(2):337-46
12614674
Neurosci Lett. 1992 Nov 23;147(1):16-20
1336151
Nat Rev Neurosci. 2006 May;7(5):335-46
16760914
J Neurophysiol. 2005 Sep;94(3):2073-85
15987761
Neuroscience. 2000;100(3):549-56
11098118
Glia. 2004 Aug 15;47(3):258-67
15252815
Pflugers Arch. 2004 Nov;449(2):132-42
15338308
Br J Pharmacol. 1994 Oct;113(2):536-40
7834205
J Comp Neurol. 1980 Dec 1;194(3):555-70
7451682
Annu Rev Physiol. 2001;63:795-813
11181976
Neuron. 1998 Apr;20(4):783-95
9581769
Neuron. 2002 Feb 14;33(4):625-33
11856535
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2151-5
14766975
Brain Res Mol Brain Res. 1994 Oct;26(1-2):47-54
7854065
Acta Physiol Scand. 2003 Jan;177(1):17-26
12492775
Neuroscience. 1998 Apr;83(3):815-28
9483565
Brain Res. 1998 Apr 27;791(1-2):317-20
9593966
J Physiol. 2003 Apr 1;548(Pt 1):97-110
12588900
J Neurophysiol. 2003 Oct;90(4):2690-701
12815026
Trends Neurosci. 2004 Jan;27(1):30-40
14698608
Brain Res Brain Res Rev. 2004 Jul;45(3):196-212
15210304
J Neurosci. 1996 Oct 1;16(19):6255-64
8815906
Neuron. 2003 Dec 18;40(6):1059-61
14687541
Nature. 2001 Jan 4;409(6816):88-92
11343119
Eur J Neurosci. 1997 Mar;9(3):533-48
9104595
Am J Physiol. 1998 Sep;275(3):R728-34
9728069
Peptides. 2004 Mar;25(3):403-11
15134863
Eur J Pharmacol. 2003 Oct 31;479(1-3):127-37
14612144
J Comp Neurol. 1996 Apr 15;367(4):595-606
8731228
Trends Neurosci. 1994 Dec;17(12):517-25
7532336
Mol Pharmacol. 2003 Jan;63(1):2-8
12488530
J Neurosci. 2000 Jun 1;20(11):4091-8
10818144
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2847-56
16877560
Nat Rev Neurosci. 2005 Mar;6(3):215-29
15738957
J Physiol. 1998 Nov 1;512 ( Pt 3):643-9
9769410
Am J Physiol Heart Circ Physiol. 2001 Sep;281(3):H1233-41
11514292
Trends Neurosci. 1999 May;22(5):208-15
10322493
J Comp Neurol. 2006 Feb 1;494(4):673-85
16374796
Neuroscience. 1984 Jul;12(3):783-91
6472620
J Neurophysiol. 1992 Jun;67(6):1698-701
1629773